Cortinas de álamo

Un recurso forestal con futuro en la PatagoniaEn la actualidad, existen aproximadamente 11.324 km de cortinas forestales de álamos en la región Patagónica. En el Alto Valle de Río Negro y Neuquén, donde se concentra la mayoría de los álamos en Patagonia, constituyen un importante recurso forestal. Los usos de su madera son muy variados y se encuentran en continua evolución, desarraigándose la idea de que son maderas de baja calidad. Actualmente se proyecta en la región un importante desarrollo en la industria maderera, lo que posiciona a estos árboles como un recurso forestal potencial. Docentes y estudiantes de la Universidad Nacional del Comahue estudian su madera con el fin de generar información necesaria para abrir aún más el abanico de sus posibilidades de uso. Los resultados obtenidos la ubican en posición competitiva con otras maderas utilizadas con fines estructurales

HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal

Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in a variety of conditions including peritoneal dialysis (PD), post-surgery adhesions and peritoneal metastases. The acquisition of invasive and pro-fibrotic abilities by mesothelial cells (MCs) through induction of MMT, a cell-specific form of EMT, plays a main role in this process. Aim of this study was to evaluate possible effects of histone deacetylase (HDAC) inhibitors, key components of the epigenetic machinery, in counteracting MMT observed in MCs isolated from effluent of PD patients. HDAC inhibitors with different class/isoform selectivity have been used for pharmacological inhibition. While the effect of other inhibitors was limited to a partial E-cadherin re-expression, MS-275, a HDAC1-3 inhibitor, promoted: (i) downregulation of mesenchymal markers (MMP2, Col1A1, PAI-1, TGFβ1, TGFβRI) (ii) upregulation of epithelial markers (E-cadherin, Occludin), (iii) reacquisition of an epithelial-like morphology and (iv) marked reduction of cellular invasiveness. Results were confirmed by HDAC1 genetic silencing. Mechanistically, MS-275 causes: (i) increase of nuclear histone H3 acetylation (ii) rescue of the acetylation profile on E-cadherin promoter, (iii) Snail functional impairment. Overall, our study, pinpointing a role for HDAC1, revealed a new player in the regulation of peritoneal fibrosis, providing the rationale for future therapeutic opportunities

Propiedades mecánicas de la madera de álamos de cortinas forestales de Río Negro, Patagonia, Argentina

En la provincia de Río Negro, Argentina, existen en la actualidad 6000 km de longitud lineal de cortinas cortavientos de álamo. Su función principal es la protección de cultivos frutihortícolas, pero son además un recurso forestal real y potencial. El objetivo de este trabajo es conocer algunas propiedades mecánicas de la madera estos álamos, información no existente y esencial para optimizar su aprovechamiento y maximizar su valor en diferentes usos. Se apearon 15 ejemplares de los álamos más representados en cortinas forestales (álamo chileno, conti 12 y boleana) de chacras de la localidad de Allen. De cada árbol se extrajo una troza de 1,5 m de largo desde la cual se obtuvieron probetas para ensayos de propiedades mecánicas de resistencia estática de flexión, compresión (Norma ASTM D-143), resistencia al aplastamiento (Norma ASTM D-5764-97) y dureza (Norma IRAM-9570). Por un lado, los resultados obtenidos fueron del orden de los reportados para madera de otros álamos cultivados en diferentes zonas de nuestro país, algunas de ellas habilitadas para uso estructural. Por otro lado, los valores obtenidos fueron del rango de los reportados para pino ponderosa, madera ampliamente utilizada en Patagonia en la construcción de cabreadas, estructuras portantes (tirantes, vigas, columnas, etc.) y bastidores de entramados en paneles estructurales. La madera de boleana y conti 12 presentó mayores valores de resistencia a la flexión, a la compresión y al desgaste que la del álamo chileno (MOR flexión: 66,7 Mpa, MOE flexión: 8562,15 Mpa, MOR compresión: 31,22 Mpa, MOE compresión: 8270,52 Mpa, dureza radial: 1,63 kN/cm2). La resistencia al aplastamiento no presentó variaciones significativas entre ellos (conti 12: 29,42 Mpa, boleana: 30,08 Mpa y chileno: 29,65 Mpa). Estos resultados resaltan el potencial que presenta la madera de los álamos de cortinas forestales de los valles irrigados de Río Negro para ampliar sus posibilidades de uso.In Río Negro province, Argentina, there are currently 6000 km of linear length of poplar windbreaks. Its main function is the protection of fruit and vegetable crops but they are also a real and potential forest resource. The objective of this work is to know the mechanical properties of the wood these poplars, nonexistent and essential information to optimize their use and maximize their value in different uses. Fifteen specimens of the most represented poplars in forest curtains (chileno, conti 12 and boleana) of farms in Allen were cutted. From each tree a 1.5 m long log was extracted to obtain wood for mechanical properties tests of static resistance of bending, compression (ASTM D-143), dowel bearing strenght (ASTM D-5764-97) and hardness (IRAM-9570). The results obtained were of the order of those reported for wood from other poplars grown in different areas of our country, some of them accepted for structural use. On the other hand, the values obtained were from the range of those reported for ponderosa pine, wood widely used in Patagonia in the construction, load-bearing structures (beams, columns, etc.) and frames of trusses in structural panels. The wood of boleana and conti 12 presented higher values of resistance to flexion, compression and hardness than chilean poplar (MOR flexion: 66.7 Mpa, MOE flexion: 8562.15 Mpa, MOR compression: 31.22 Mpa, MOE compression: 8270.52 MPa, radial hardness: 1.63 kN / cm2). The dowel bearing strenght did not show significant variations among them (conti 12: 29.42 MPa, boleana: 30.08 MPa and chilean: 29.65 MPa). These conclusions highlight the potential of poplar wood from Río Negro forest windbreaks to expand their possibilities of use.Fil: Medina, A.A. Universidad Nacional del Comahue, Asentamiento Universitario San Martín de los Andes; ArgentinaFil: Manzione, Pablo. Universidad Nacional del Comahue. Facultad de Ingeniería. Departamento de Mecánica Aplicada. Grupo de Estudio de Polímeros Sintéticos y Naturales; ArgentinaFil: Baucis, Agustín. Universidad Nacional del Comahue, Asentamiento Universitario San Martín de los Andes; ArgentinaFil: Catalán, Mariano. Universidad Nacional del Comahue, Asentamiento Universitario San Martín de los Andes; ArgentinaFil: Laffitte, Lorena. Universidad Nacional del Comahue, Asentamiento Universitario San Martín de los Andes; ArgentinaFil: Andía, Ismael R. Universidad Nacional del Comahue, Asentamiento Universitario San Martín de los Andes; Argentin

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

BACKGROUND: Carboplatin/paclitaxel is the chemotherapy of choice for advanced ovarian cancer, both in first line and in platinum-sensitive recurrence. Although a significant proportion of patients have some neurotoxicity during treatment, the long-term outcome of chemotherapy-induced neuropathy has been scantly studied. We retrospectively assessed the prevalence of residual neuropathy in a cohort of patients in clinical remission after first-line carboplatin/paclitaxel for advanced ovarian cancer. METHODS: 120 patients have been included in this study (101 participating in a multicentre phase III trial evaluating the efficacy of consolidation treatment with topotecan, and 19 treated at the National Cancer Institute of Naples after the end of the trial). All patients received carboplatin (AUC 5) plus paclitaxel (175 mg/m(2)) every 3 weeks for 6 cycles, completing treatment between 1998 and 2003. Data were collected between May and September 2004. Residual sensory and motor neurotoxicity were coded according to the National Cancer Institute – Common Toxicity Criteria. RESULTS: 55 patients (46%) did not experience any grade of neurological toxicity during chemotherapy and of these none had signs of neuropathy during follow-up. The other 65 patients (54%) had chemotherapy-induced neurotoxicity during treatment and follow-up data are available for 60 of them. Fourteen out of 60 patients (23%) referred residual neuropathy at the most recent follow-up visit, after a median follow up of 18 months (range, 7–58 months): 12 patients had grade 1 and 2 patients grade 2 peripheral sensory neuropathy; 3 patients also had grade 1 motor neuropathy. The remaining 46/60 patients (77%) had no residual neuropathy at the moment of interview: recovery from neurotoxicity had occurred in the first 2 months after the end of chemotherapy in 22 (37%), between 2 and 6 months in 15 (25%), or after more than 6 months in 9 patients (15%). Considering all 120 treated patients, there was a 15% probability of persistent neurological toxicity 6 months after the end of chemotherapy. CONCLUSION: A significant proportion of patients with advanced ovarian cancer treated with first-line carboplatin/paclitaxel suffer long-term residual neuropathy. This issue should be carefully taken into account before considering re-treatment with the same agents in sensitive recurrent disease

Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis.

BACKGROUND: Kidney transplantation (KT) may restore fertility in CKD. The reasons why materno-foetal outcomes are still inferior to the overall population are only partially known. Comparison with the CKD population may offer some useful insights for management and counselling.Aim of this study was to analyse the outcomes of pregnancy after KT, compared with a large population of non-transplanted CKD patients and with low-risk control pregnancies, observed in Italy the new millennium. METHODS: We selected 121 live-born singletons after KT (Italian study group of kidney in pregnancy, national coverage about 75%), 610 live-born singletons in CKD and 1418 low-risk controls recruited in 2 large Italian Units, in the same period (2000-2014). The following outcomes were considered: maternal and foetal death; malformations; preterm delivery; small for gestational age baby (SGA); need for the neonatal intensive care unit (NICU); doubling of serum creatinine or increase in CKD stage. Data were analysed according to kidney diseases, renal function (staging according to CKD-EPI), hypertension, maternal age, partity, ethnicity. RESULTS: Materno-foetal outcomes are less favourable in CKD and KT as compared with the low-risk population. CKD stage and hypertension are important determinants of results. KT patients with e-GFR >90 have worse outcomes compared with CKD stage 1 patients; the differences level off when only CKD patients affected by glomerulonephritis or systemic diseases ('progressive CKD') are compared with KT. In the multivariate analysis, risk for preterm and early-preterm delivery was linked to CKD stage (2-5 versus 1: RR 3.42 and 3.78) and hypertension (RR 3.68 and 3.16) while no difference was associated with being a KT or a CKD patient. CONCLUSIONS: The materno-foetal outcomes in patients with kidney transplantation are comparable with those of nontransplanted CKD patients with similar levels of kidney function impairment and progressive and/or immunologic kidney diseas

Steroid and cyclosporine therapy in idiopathic membranous nephropathy. monocentric experience and literature review

Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due to its possible side effects. The 2012 KDIGO guidelines suggest alkylating agents as first choice therapy. The aim of the study is to retrospectively evaluate the induction and maintenance of clinical remission in patients with histological diagnosis of IMN undergoing steroid and/or cyclosporine therapy at the Nephrology Unit of the Sant'Andrea Hospital in Rome

Metformin associated lactic acidosis (MALA). clinical profiling and management

Metformin (MF) accumulation during acute kidney injury is associated with high anion gap lactic acidosis type B (MF-associated lactic acidosis, MALA), a serious medical condition leading to high mortality. Despite dose adjustment for renal failure, diabetic patients with chronic kidney disease (CKD) stage III-IV are at risk for rapid decline in renal function by whatever reason, so that MF toxicity might arise if the drug is not timely withdrawn. Sixteen consecutive patients were admitted to our Hospital's Emergency Department with clinical findings consistent with MALA. Fifteen had prior history of CKD, 60 % of them with GFR between 30 and 60 ml/min. Of these, 5 required mechanical ventilation and cardiovascular support; 3 promptly recovered renal function after rehydration, whereas 10 (62 %) required continuous veno-venous renal replacement treatment. SOFA and SAPS II scores were significantly related to the degree of lactic acidosis. In addition, lactate levels were relevant to therapeutic choices, since they were higher in dialyzed patients than in those on conservative treatment (11.92 mmol/l vs 5.7 mmol/l, p = 0.03). The overall death rate has been 31 %, with poorer prognosis for worse acidemia, as serum pH was significantly lower in non-survivors (pH 6.96 vs 7.16, p > 0.04). Our own data and a review of the literature suggest that aged, hemodynamically frail patients, with several comorbidities and CKD, are at greater risk of MALA, despite MF dosage adjustment. Moreover, renal replacement therapy rather than simple acidosis correction by administration of alkali seems the treatment of choice, based on eventual renal recovery and overall outcome

[Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review]

Abstract INTRODUCTION: Immunosuppressive treatment of patients with idiopathic membranous nephropathy (IMN) is debated due to its possible side effects. The 2012 KDIGO guidelines suggest alkylating agents as first choice therapy. The aim of the study is to retrospectively evaluate the induction and maintenance of clinical remission in patients with histological diagnosis of IMN undergoing steroid and/or cyclosporine therapy at the Nephrology Unit of the Sant'Andrea Hospital in Rome. MATERIALS AND METHODS: Therapy A (conservative) was reserved to low-risk patients. 8 medium and high risk patients were induced by Therapy B (Prednisone 1 mg / kg 6412-16 weeks plus 8 weeks withdrawal); 6 patients by Therapy C (Prednisone 1 mg /kg 6520-24 weeks plus 8 week withdrawal) and, finally, 6 steroid-resistent patients by Therapy D (steroid withdrawal + cyclosporine 3-5 mg / kg for 2 years). RESULTS: Complete remission was observed in 37.5% of patients in Therapy B, in 83.3% of patients in Therapy C and in 66.6% of patients in Therapy D. Patients in group B relapsed more frequently than patients in the other groups. Side effects were irrelevant. CONCLUSIONS: In view of the potential cytotoxicity of alkylating agents, steroids are a valid alternative in inducing and maintaining clinical remission over time, when administered with a more aggressive induction scheme. In cases of steroid resistance or rapid relapse, cyclosporine is a valid alternative to alkylating agents